Medical News
Addiction
Allergies
Alternative Medicine
Asthma
Cancer
Cardiology
Chiropractic
Dental
Dermatology
Diabetes
Emergency
Family Medicine
General
Geriatrics
Hospitals
Infectious Diseases
Internal Medicine
Managed Care / HMO
Medical Products
Mental Health
Neurology
Nursing
Nutrition
OB / GYN
Pediatrics
Pharmaceuticals
Physical Therapy
Plastic Surgery
Psychology
Radiology / Imaging
Research
Sports Medicine
Surgery
Vision

Investigators to Meet at Summit to Advance Clinical Research for Spinal Muscular Atrophy

Fight SMA
Fight SMA

With the recent introduction of SMA legislation in both the U.S. House of Representatives and the U.S. Senate to create a national clinical trials network for spinal muscular atrophy (SMA), the leading advocacy organizations are hosting a two-day summit to work toward reducing or eliminating barriers to development of the drugs that would be tested in that network.

Bethesda, MD (PRWEB) September 28, 2007 -- With the recent introduction of SMA legislation in both the U.S. House of Representatives and the U.S. Senate to create a national clinical trials network for spinal muscular atrophy (SMA), the leading advocacy organizations are hosting a two-day summit to work toward reducing or eliminating barriers to development of the drugs that would be tested in that network.

The SMA Summit on Drug Development, which is being held on September 28 and 29 at the Hyatt Regency Bethesda, in Bethesda, MD, will include representatives from the pharmaceutical industry, family support groups, clinicians and government. These stakeholders in the clinical research process will discuss infrastructure, regulatory, and community support needs for evaluating treatments in development. The goal is to speed the development and approval of drugs designed to treat SMA, for which there is currently no approved treatment.

Spinal muscular atrophy is a neuromuscular disease that kills more children under two than any other genetic disorder. It affects the victim's motor neurons, causing muscle atrophy, loss of strength, disability and premature death due to respiratory complications in the majority of affected children.

Both the bill and the drug summit were conceived and implemented through the collaboration of SMA organizations and other parties that have an interest in accelerating a treatment and cure for this disease. These efforts are in anticipation of clinical trials to test new drug treatments for SMA.

Media Contacts:

Lenna Scott
Families of SMA
http://www.fsma.org
(847) 975-4171
lenna(at)fsma.org

Steve Mullen
Fight SMA
http://www.fightsma.org
(804) 382-0017
steve(at)endgamepr.com

Cynthia Joyce
SMA Foundation
http://www.smafoundation.org
(646) 253-7102
cjoyce(at)smafoundation.org

Bob Mackle
MDA
http://www.mdausa.org
(520) 529-5317
bobmackle(at)mdausa.org

###

Simillar Articles

Fundraiser Nets More Than $150,000 for Spinal Muscular Atrophy Research
The fight against spinal muscular atrophy just received a an infusion of money, thanks to participants in a recent fundraiser held by Fight SMA (http://www.fightsma.org).
Fight SMA Provides Grant to PTC Therapeutics, Inc. to Support Research of New Treatments for...
Fight SMA (http://www.fightsma.org) has established a research and development collaboration with PTC Therapeutics, Inc (PTC) to identify and develop a compound that can be used to treat spinal...
Spinal Muscular Atrophy Fundraisers Successful in Birmingham and Atlanta, Thanks to Dedication of...
Two fundraisers to benefit Fight SMA, held in different cities on the same day, were successful thanks to the hard work and dedication of the volunteer organizers. Fight SMA...
Spinal Muscular Atrophy Organization Wins Two Grants For National Conferences
Richmond, Virginia-based Fight SMA (http://www.fightsma.org) has been awarded two grants to fund national conferences.
Unique Auction Items to "Make Tracks" Toward Curing Spinal Muscular Atrophy
Fight SMA (http://www.fightsma.org), an international nonprofit organization working to accelerate a treatment or cure for spinal muscular atrophy, is announcing the list of items available at the...
Home Terms of Use Privacy Policy Contact Us